Gene expression is finely regulated to ensure that the correct complement of RNA and proteins is present in the right cell at the correct time. Owing to its diversity -in sequence and structure -RNA has crucial roles in cell biology and is regulated by numerous proteins that modulate its content and spatial-temporal expression. Methodological advances, including bioinformatic, microarray-based, biochemical and deep-sequencing studies, are producing new insights into the roles that the regulation of RNA complexity -the sum of the unique isoforms of RNA in a cell, including mRNA variants, non-coding RNAs and microRNAs (miRNAs) -has in generating organismal complexity from a relatively small number of genes. Here we review this progress, focusing on mRNAs and the ways in which the technological advances are beginning to revolutionize our ability to understand the mechanisms and consequences of mRNA diversification.
of adenovirus mRNA-DNA hybrids 5, 6 -that allowed the relationship between the precursors and mRNA products of adenoviral transcripts to be examined at the nucleotide level. These efforts revealed that adenoviral mRNA has "an amazing sequence arrangement" (REF. 6 ), such that the processing of pre-mRNA to mature mRNA involves the intramolecular joining (splicing) of expressed sequences (exons) that are separated by noncoding intervening sequences (introns) 7 in the primary transcript (FIG. 1) . This was quickly recognized as a general feature of eukaryotic RNA processing 8, 9 . The discovery of splicing led to the realization that RNA has the potential to be more complex than DNA 7, 10 . This potential was shown by the findings, first made in adenovirus 11 and subsequently in eukaryotic cells during cell differentiation 12 and in tissues 13 , that alternative mRNA products could be generated from a single pre-mRNA precursor in a regulated manner. In this way regulation of alternative splicing and polyadenylation allows a single gene to encode multiple mRNAs that possess distinct coding and regulatory sequences.
A more recent epoch in understanding RNA complexity was ushered in with the ability to sequence complete genomes, and the concomitant realization that humans and worms have approximately the same number of proteincoding genes (and more recently that human and chimpanzee genomic-coding regions are 99.7% identical) 14 . These observations, together with the development of the 'RNA World' hypothesis 15, 16 , led to a new concept that is explored in this Review. This concept is that biological Nature Reviews | Genetics and 'E'). Further mRNA diversification can result from alternative selection of poly(A) sites (pA) in the same 3′ terminal exon (pA2 versus pA3 in the 'E' exon), generating mRNA isoforms with a short or long 3′ UTR. Additional events (not shown) can further diversify the resulting mRNA pool, including transcription initiation at an alternative promoter, selection of alternative 3′ or 5′ splice sites (which change exon length), intron retention and RNA editing. m 7 G, 5′ cap.
complexity -the variation in cell type and function -has RNA complexity at its core. In this view it is the intricate unfolding of the genetic information in DNA into diverse RNA species -mediated by RNA-protein interactions -that leads to biological variation that is not evident from the analysis of DNA sequence alone. The known roles of RNA in the cell have expanded from RNA being a machine and template for protein synthesis to it acting as a regulatory hub for posttranscriptional control. There are also emerging and still incompletely understood roles of RNA as a trans-acting factor that can regulate the expression of genetic information. For example, miRNAs 17 , piwi-interacting RNAs (piRNAs) 18 and long non-coding RNAs 19, 20 direct different RNA-binding proteins (RNABPs) to their regulatory targets to suppress translation 21 , provide protection from transposable elements 18 and mediate epigenetic changes 1, 22, 23 , respectively. Adding to the versatility of RNA, transcripts are diversified from the point of transcription onwards through a plethora of mechanisms, including alternative transcription initiation [24] [25] [26] , alternative splicing [27] [28] [29] , alternative polyadenylation 30 , RNA editing 31 and post-transcriptional modification (pseudouridylation 32 , methylation 33 and non-canonical polyadenylation and RNA terminal polyuridylation 34, 35 ). Once generated, mature RNA isoforms are subject to many levels of regulation that include the regulation of translation by miRNAs 21 and regulatory factors 36 , the use of alternative translational start sites 37 , RNA localization 38 and mRNA stability and turnover 39, 40 . RNA regulation is achieved through the concerted action of multiple RNABPs 41 that bind to 'core' and 'auxiliary' elements, which are required for and modulate pre-mRNA processing events, respectively (FIG. 2) . Core splicing elements demarcate exons and the sequences required for their splicing. Auxiliary splicing elements, which are located in introns and/or exons, bind factors that enhance or inhibit splicing. Similarly, mRNA 3′ end maturation also depends on the presence of core and auxiliary elements that define the site of transcript cleavage and polyadenylation 42, 43 . The identification of alternative polyadenylation sites in most human genes and evidence for tissue-specific biases in alternative polyadenylation 8, [44] [45] [46] suggests that the regulation of alternative polyadenylation through auxiliary control might be a common mechanism to diversify the transcriptome. Current interest relating to RNA complexity has three main aspects: meeting methodological challenges so that the vast amount of information present in RNA can be collated; analysis of these data sets so that new rules of RNA regulation can be detailed; and application of the new insights to achieve a basic understanding of cellular control and, ultimately, an understanding of gene deregulation in human disease. This Review will discuss each of these points -methodology, RNA analysis and, more briefly, its biological manifestations -in each case focusing on the control of RNA complexity. Although this Review touches on many aspects of RNA function, including links to transcriptional and translational regulation, space does not allow a discussion of these issues, which can be found in several excellent reviews 19 Figure 2 | Alternative splicing and polyadenylation. a | Core elements necessary for pre-mRNA splicing include the 5′ and 3′ splice sites (SS), a branch point sequence (BP) upstream of the 3′ SS, and a polypyrimidine-rich tract (PPT) between the BP and the 3′ SS. All of these elements are bound by components of the spliceosome, which is a dynamic macromolecular complex that consists of small nuclear RNAs (snRNAs) and ~170 proteins 29 . Auxiliary sequences are variable in number and location -they can be located in exons and in the flanking intronic sequences -and are bound by factors that generally function to either enhance or inhibit basal splicing activity. b | The combinatorial actions of both core and auxiliary splicing factors participate in the regulation of alternative splicing. For example, the serine/arginine-rich (SR) proteins comprise a family of auxiliary RNA-binding proteins (RNABPs) that bind to splicing enhancer elements to facilitate exon identification and promote splicing (although like most RNABPs they can also serve other functions in the cell). By contrast, the binding of auxiliary heterogeneous nuclear ribonucleoproteins (hnRNPs) to splicing silencer elements has a negative effect on exon inclusion; in many cases they antagonize the 'pro-splicing' activity of SR proteins. Interestingly, in addition to tissue-specific RNABPs such as Nova and Fox, the levels of some core snRNPs vary between tissues 128 and such variations might contribute to splicing regulation 41 . c | Core elements necessary for maturation of the 3′ end of a mRNA include a poly(A) signal (an adenylate-rich hexameric sequence, most often AAUAAA; PAS) and a U/GU-rich sequence, which are positioned upstream and downstream of the poly(A) site respectively. These elements direct the endonucleolytic cleavage and polyadenylation of the transcript. Although a number of auxiliary elements that affect the use of poly(A) sites have been identified 43 , the extent to which these elements regulate alternative poly(A) site use remains unclear. AUX, auxiliary factor; CF, cleavage factor; CPSF, cleavage and polyadenylation specificity factor; CSTF, cleavage stimulation factor; DSE, downstream element; Nova, neuro-oncological ventral antigen; pA, poly(A) site; PAP, poly(A) polymerase; USE, upstream element. new methods to analyse rna complexity while advances in understanding RNA regulation and complexity in the 1970s and 1980s came about through the detailed study of individual RNAs, the focus of recent technological advances is the characterization of whole RNA populations in cellular contexts at nucleotide-level resolution. Accordingly, new methods that can simultaneously analyse multiple RNA processing events are culminating in the development of genome-wide RNA maps that pave the way for new biological insights.
Microarrays. Systematic efforts to identify RNA variants began with microarray technologies. various different arrays have been used to elucidate RNA complexity. In particular, probe sets for alternative exons identified from genome sequencing efforts have been used to analyse splice variants. The first use of exon-junction microarrays to interrogate RNA populations from different tissues led to the recognition that a large number (at the time the estimate was ~75%, but see below) of human multi-exon genes are alternatively spliced 51 . Similar exon-junction arrays have been used to identify tissue-restricted patterns of alternative mRNA expression and provide insights into their regulation by specific RNABPs [52] [53] [54] . Although microarrays provide valuable data on alternative RNA processing and diversity in different biological contexts, their use has been limited by several factors. Two of these factors -the incomplete nature of gene annotations and limitations on microarray density -continually improve over time but others, such as the need to predefine targets (such as alternative exons), preclude the identification of novel alternative mRNA isoforms. One effort to address the issue of predefining targets has been the development of microarrays that can be used to interrogate 'complete' sets of transcribed exons 54 . Although these arrays do not monitor specific exon junctions, they have the advantage of expanded transcriptome coverage, which provides more reliable estimates of RNA abundance. They can also detect changes in the use of individual exons (alternatively spliced isoforms) and variants derived from differential transcription regulation or alternative polyadenylation. More complete 'genome-tiling' arrays have been developed for yeast, Drosophila melanogaster and some human chromosomes 55, 56 ; these arrays circumvent the need for prior knowledge of the transcriptome. Analyses using tiling arrays reported that most of the human genome is transcribed 57 , although the biological relevance of these findings remains uncertain 56, 58 . A final limitation of microarrays is they are dependent on nucleic acid hybridization; researchers need to consider signal-to-noise ratios that can vary owing to the differences in base composition and annealing properties between individual probes. These limitations are being addressed with a new technology -direct high-throughput sequencing.
High-throughput sequencing. RNA-seq (or nextgeneration RNA sequencing) (BOX 1) takes advantage of the power of new single-molecule sequencing methods 59, 60 that can currently produce billions of nucleotides 
RNA editing
The post-transcriptional modification of RNA primary sequence by the insertion and/ or deletion of specific bases, or the chemical modification of adenosine to inosine or cytidine to uridine.
Exon-junction microarray
A microarray platform that contains probe sets designed to detect the mRNA sequences (junctions) formed by the splicing of one exon to another.
Ultraconserved element
A large sequence in the genome (usually >200 nucleotides) that shows high levels of conservation across multiple species.
Nonsense-mediated decay
The process by which mRNAs containing premature termination codons are destroyed to preclude the production of truncated and potentially deleterious protein products. It is also used in combination with specific alternative splicing events to control the levels of some proteins.
of sequence in a matter of days for several thousand dollars. The power of RNA-seq to assess mRNA complexity was highlighted in 2008 by the Blencowe 61 and Burge 45 laboratories, who provided complete RNA profiles and analysis of alternative splicing and polyadenylation variants in different tissues that easily rivalled those that could be obtained using microarrays. The ability of RNA-seq to detect previously uncharacterized mRNA isoforms and new classes of non-coding RNAs 62 illustrates the use of this rapidly evolving technology, which is assuming an increasingly dominant role in RNA analyses. In addition, high-throughput sequencing can be coupled with hybridization strategies to enrich specific RNA populations before sequencing. This strategy balances the constraints of hybridization technologies (as with microarrays) with the advantages of high-throughput sequencing experiments, and has been effectively used to study the RNA variants generated by RNA editing 63, 64 .
Bioinformatics. Bioinformatics has emerged as a powerful complement to current efforts to analyse the complexity of cell-specific RNA signatures. Sequence-based bioinformatic approaches have long been applied to the study of pre-mRNA processing and have revealed consensus sequences that define the 5′ splice site 65 , the poly(A) signal that is necessary for 3′ end maturation and termination of transcription 66, 67 , and atypical consensus sequences that define an alternative means for regulating splicing 68 . Current bioinformatic efforts are aided by and are also dependent on improvements in the number and depth of sequences available from expressed sequence tag (eST) and cDNA libraries, microarray data sets and whole-genome sequencing. Therefore, bioinformatics is likely to become more powerful as new technology improves such databases. The comparison of RNA profiles from different cell types and organisms has helped to determine the frequency of alternative processing and the extent to which it is subject to species-or tissue-specific regulation. In addition, analyses of sequences associated with conserved alternative processing events have helped to develop an understanding of several aspects of alternative processing, including: identifying sequence elements that are potentially associated with the regulation of alternative processing 52, [69] [70] [71] [72] ; investigating the origins of alternative splicing 73 ; and defining unexpected features, such as ultraconserved elements that mediate nonsense-mediated decay (NMD) of transcripts that encode RNABPs 74 . Although not the focus of this Review, bioinformatics has also been used in efforts to identify miRNA targets 47 and other regulatory elements in 3′ uTRs 38-40. Methods to study protein-RNA interactions. Bioinformatic, microarray and high-throughput sequencing studies have provided an unprecedented ability to describe RNAs on a genome-wide scale and to suggest which cis elements and trans-acting factors are associated with RNA regulation. However, these methods are limited without biochemical methods to identify the direct RNABP-RNA interactions that define RNA regulation in vivo. In general, researchers wish to distinguish between the primary (direct) and secondary (indirect) effects of RNA regulatory factors. For example, in the fragile X syndrome, the loss of fragile X mental retardation 1 protein (FMRP) function is clearly the proximal cause of the disorder. Therefore, there is great interest in identifying the RNAs that FMRP regulates in neurons and in distinguishing these direct effects from the RNA deregulation owing to secondary or tertiary consequences of FMRP loss 75 . Put another way, any perturbation in a cell is likely to disrupt the RNA profile of that cell, as detected by methods such as microarrays or RNA-seq. Therefore, such changes in RNA profiles cannot be taken as evidence of the specific action of a RNABP. Attempts to study mechanisms of RNA regulation in cells depend on distinguishing between the direct and indirect consequences of cellular manipulations.
Multiple approaches have emerged for the biochemical identification of functional RNABP-RNA interactions in vivo. These include immunoprecipitation of RNABPs followed by purification of the co-precipitating RNA and analysis by RT-PCR or microarrays 76, 77 . These strategies have proven useful but they cannot discriminate between direct and indirect interactions or identify RNA-protein-binding sites. Moreover, they are limited by the need to use relatively low stringency conditions to maintain protein-RNA interactions and such conditions are associated with problems related to signal-to-noise ratios, co-precipitating RNABPs and RNABP-RNA reassociation in vitro [78] [79] [80] . An alternative means of identifying regulatory RNABP-RNA interactions is the ClIP (crosslinking and immunoprecipitation) assay 78, 81, 82 
. ClIP applies the observation -first made in the study of tRNA-protein interactions in the 1970s 83 and even earlier for DNA-protein interactions -that ultraviolet (uv)-irradiation causes covalent crosslinking between RNA-protein complexes that are in tight apposition (that is, within ~Ångstrom distances). uv-crosslinking was applied in a cellular context in studies of protein-RNA interactions by van venrooij 84 and Pederson 47,85,86
Box 1 | rna-seq
The term RNA-seq applies to any of several different high-throughput (next-generation) sequencing methods to obtain transcriptome-wide RNA profiles 59 . Typically, RNA from two samples that are to be compared is sheared, converted to cDNA and sequenced. Using current technology this can yield up to 25 million sequence reads that are ~35 nucleotides in length 45 . Although there can be sequencing bias at any particular position in the genome -for example, depending on the GC content and/or the propensity of that sequence to be amplified by PCR -such errors will be the same across different samples. Therefore, differences between samples can be quantified at the resolution of individual splice variants 45 or even edited RNA nucleotides 63 . Other applications of RNA-seq using different sequencing strategies include looking at pools of RNA that are being translated by sequencing RNA bound to ribosomes 159 and single-cell RNA analysis 162 . Currently 2.5 × 10 7 sequence reads can detect 2.5 × 10 5 different transcripts. This means that abundant transcripts are represented by many reads and rare transcripts by only a few reads; the sensitivity of this technique is likely to improve over time. Nature Reviews | Genetics in the 1980s, and the methods were then refined by immunoprecipitation of crosslinked heterogeneous nuclear ribonucleoprotein (hnRNP)-RNA complexes by Dreyfuss 87 and colleagues. ClIP allows the purification of RNABP-RNA interactions occurring in live cells, or even whole tissues such as the brain, to be covalently 'locked' in place and rigorously purified. This yields a population of RNA sequences that are directly bound by the RNABP of interest. Sequencing this population provides a means of identifying the bound RNA and, importantly, the position of protein binding. ClIP (and emerging methodological improvements to this method 81, 82, [88] [89] [90] [91] ), established that small, crosslinked RNA fragments could be amplified by RT-PCR after partial RNase and proteinase K digestion. This approachinitially using conventional cloning strategies 92 and, more recently, using high-throughput sequencing (HITS-ClIP) 88 -reveals the RNA 'sequence footprints' that are bound by RNABPs and provides a powerful way to study RNA-protein interactions in living tissues at a transcriptome-wide level 1, 41, 59 . So far, HITS-ClIP has been used to generate high-resolution genomewide assessments of RNABP-RNA interactions in mouse brain 88 , stem cells 90 and tissue culture cells 93 , and also to deconvolute Argonaute (Ago)-miRNA-mRNA ternary interactions in the mouse brain 91 (discussed further below).
Biological complexity from rna regulation
As new methods have improved the ability to assess mRNA complexity, estimates of the extent to which alternative RNA isoforms contribute to functional diversity have increased. Recent efforts to characterize the mRNA signature of different human tissues using RNA-seq have revealed that nearly all multi-exon
Box 2 | clip and Hits-clip methods
Crosslinking and immunoprecipitation (CLIP) takes advantage of the ability of ultraviolet (UV)-irradiation to penetrate intact cells or tissues and induce covalent crosslinks between RNA and proteins that are in direct contact (~1 Ångstrom apart). A flow diagram of the experimental steps is shown in the figure above. Once they have been covalently bound, RNA-protein complexes can be purified under stringent conditions, which gives the advantage of being able to separate them from closely bound RNA-binding protein (RNABP)-RNABP complexes, reassociated RNAs and background RNAs. After purification, CLIP 81, 82, 92 uses proteinase K to remove the RNABP. This is followed by linker ligation and RT-PCR to analyse the RNA sequences. This sequencing analysis can be done using high-throughput sequencing methods, in which case it is referred to as 'HITS-CLIP' (REFS 88, 91) . The details of HITS-CLIP are likely to be modified and improved over time. For example, more efficient sequencing and the use of ever-smaller sample sizes are likely to be possible. Current methods and algorithms for analysing HITS-CLIP data can be found at R.B.D.'s homepage (see Further information box). It should be noted that it remains to be determined whether HITS-CLIP has limitations in terms of efficiency of crosslinking specific subsets of RNA-protein interactions. However, to date microarray and HITS-CLIP studies have yielded similar results 53, 88 , which suggests that crosslinking can be highly efficient across the transcriptome.
human genes (comprising >90% of all genes) generate alternative mRNA isoforms and most do so in a tissuespecific manner 45, 61 . These alternative isoforms include variants that arise from alternative transcription initiation and from all known forms of alternative pre-mRNA processing. In addition high-throughput sequencing combined with target enrichment has been used to assess the diversity generated by the over 36,000 sites at which RNA editing occurs 63 . All of these means of modifying RNA transcripts generate complexity of both protein-coding mRNAs and ncRNAs; we focus here on RNA as the regulated substrate (instead of DNA as the substrate, which is reviewed elsewhere 24, 26, 41 ) and note that, to date, most experimental validation has been achieved using protein-coding mRNAs.
Alternative splicing. Alternative splicing is one of the major ways in which RNA diversity is generated. The comparative analysis of splicing variants is yielding insights into the biological consequences of this process 76, [94] [95] [96] [97] . Interestingly, RNA-seq-based characterization of tissue transcriptomes, together with microarray analyses 52, 54, 69 and comparative bioinformatic studies 71, 98 , identified the mammalian brain as the tissue that expresses the greatest number of alternative mRNA isoforms. This is likely to be related to the fact that this tissue is populated by thousands of highly specialized unique cell types that undergo dynamic changes. In the nervous system, alternative splicing has many important roles, including controlling the spatial and temporal expression of isoforms that are necessary for neurodevelopment and the modification of synaptic strength 95, 99 . Important general issues regarding the complexity of alternative splicing are highlighted by contrasting studies of Down syndrome cell adhesion molecule (DSCAM) and neurexin splicing in the nervous system. In D. melanogaster, Dscam -which is believed to be crucial for proper neural circuit formation -encodes many thousands of neuron-specific RNA variants that are produced by alternative splicing 100 . Despite the great complexity of RNA products and the recognition that RNABPs act to restrict Dscam exon usage 101 , it is believed that the choice of RNA variants produced in any one neuron is largely stochastic, and the resulting biological complexity of the RNA variants is proportionately low. each RNA variant encodes a cell surface axonal molecule that is randomly generated to be different from that on neighbouring axons, thereby yielding a unitary outcome -that is, axon self-avoidance, which is necessary for normal fasciculation 100 . The regulated rather than stochastic production of alternative RNA variants has the potential to generate great diversity of biological function. The alternative splicing of neurexin pre-mRNA in mammalian brain provides an interesting example. Nearly 3,000 unique neurexin transcripts are derived from the combination of 3 genes, each of which has 2 alternate promoters and encodes transcripts with ~10 alternate exons 102 . This set of alternate transcripts encodes variants that give rise to alternative neurexin protein isoforms, which have different interactions with different neuroligan protein isoforms across the synaptic cleft. This suggests that a 'splice code' might underlie trans-synaptic cell adhesion 103 . There is evidence that a few RNABPs might regulate neurexin (and neuroligan) isoforms 95 , suggesting that a small number of RNA regulatory proteins may generate a great diversity of biological outcomes 103 . These observations also underscore the more general point that alternative splicing plays a major part in biological complexity 28 .
Alternative polyadenylation. Although it is clear that alternative processing of pre-mRNA can confer different structural and functional properties on proteins 76, 104 , additional functional roles for alternative processing in the regulation of gene expression have also emerged. Consistent with eST-based bioinformatic studies 46 , RNA-seq analysis identified tissue-specific biases in the regulation of tandem polyadenylation sites (FIGS 2,3a). unlike the alternative poly(A) site regulation that is coupled to the inclusion of an alternative 3′ terminal exon (FIG. 1) , alternative polyadenylation at tandem poly(A) sites can yield transcripts that have identical protein-coding sequences but different 3′ uTR sequences. This provides the potential for differential regulation of mRNA expression by RNABPs and/or miRNAs (FIG. 3a) . exon microarray and RNA expression studies have indicated that such regulation might have important biological consequences. Proliferating cells, such as activated T lymphocytes 105 and tumour cells 106 , harbour shortened 3′ uTRs. By contrast, the brain, which is a non-proliferative tissue, seems to regulate polyadenylation so that transcripts harbour on average longer 3′ uTRs 45, 88 . These studies suggest that these differing cell types regulate polyadenylation in opposite ways to allow RNA to escape from or be subjected to different levels of regulation. There are likely to be multiple mechanisms of 3′ uTR regulation, including miRNA-mediated regulation of translation 105, 106 , RNA localization 38 and RNA stability 39, 40 .
Alternative splicing coupled to NMD. A recently recognized example in which alternative processing is coupled to post-transcriptional control is that of alternative splicing events that result in the introduction of a premature termination codon (PTC), which targets mRNA for degradation by NMD (REFS 24,48,107) (FIG. 3b) . Although eST-based bioinformatic studies 108, 109 had suggested that alternative splicing coupled to NMD (AS-NMD) is a widely used mechanism for controlling RNA abundance, how widespread it is remains unclear. However, AS-NMD has been shown to regulate the expression of many splicing regulatory factors (some in an autoregulatory manner), including serine/arginine-rich (SR) proteins 74 , hnRNPs [110] [111] [112] and core spliceosomal proteins 109 . Interestingly, some of the exons for which splicing or skipping results in a PTC are associated with ultraconserved elements 74, 113 . This suggests that AS-NMD might be an evolutionarily ancient mechanism that is used to establish the correct balance of nuclear RNABPs necessary to generate cell type-and developmental stage-specific mRNA profiles 110, 111 . Nature Reviews | Genetics regulating rna complexity The dependence of pre-mRNA processing events on multiple RNABP-RNA interactions provides multiple steps at which processing can be regulated. Core elements can be directly involved in the regulation of exon usage through the regulation of core factor stoichiometry 29, 114 . Similarly, SR proteins and hnRNPs are widely expressed, yet changes in their stoichiometry can mediate tissue-specific differences in alternative splicing [115] [116] [117] . Additionally, the activity of RNABPs can be regulated by post-translational mechanisms, including phosphorylation and subcellular sequestration in response to cellular or metabolic stress 41, 118 . Such mechanisms can convert a general splicing repressor to a sequence-specific splicing activator 119 . Therefore, it is not sufficient to rely solely on correlative expression data to build models of RNA regulation in vivo.
Another layer of pre-mRNA regulation is imparted by tissue-specific RNABPs. Multiple examples of highly related factors with non-overlapping patterns of expression have been described, including the neuro-oncological ventral antigen (Nova) proteins NOvA1 and NOvA2 (REF. 78 ), the polypyrimidine tract-binding proteins (PTBPs) [120] [121] [122] , embryonic lethal abnormal visual (elav, also known as Hu) proteins 123 , Fox proteins 72, 90 , and the CelF and muscleblind (MBNl) proteins 97, 124 . Although many homologous tissue-restricted factors show high levels of conservation, multiple mechanisms provide each homologue with a unique pattern of expression, which suggests the homologues have distinct functional roles. For example, cross-regulation at the RNA level ensures that PTBP1 and PTBP2 have mutually exclusive expression patterns in mouse and human cells, and this is believed to be crucial for the regulation of neuronal differentiation 110, 111, 122 . In general, it is anticipated that the relative amounts of different positive-and negativeacting RNABPs might define a 'cellular RNA-processing code' that dictates the pattern of processing for each pre-mRNA, so that pre-mRNAs with the same set of regulatory elements can be regulated in a coordinate manner 96, [125] [126] [127] . As detailed below, the application of new methods are advancing these concepts in expected and unexpected ways and are revealing details of the mechanisms -including cis-and trans-acting codes -that underlie the establishment and regulation of cell-specific RNA profiles.
Genome-wide analysis of protein-RNA interactions.
Changes in the expression of numerous RNA regulatory proteins are coincident with changes in tissue and developmental mRNA profiles 97, 128 . A challenge for the future is to understand how the expression and activity of these regulatory factors are regulated, and how multiple factors in combination control the fate of transcribed RNA. Computational analyses have shown that alternative processing events are associated with highly conserved sequences, and have identified elements that are enriched near regulated processing sites and are therefore likely to be functionally important for protein binding and regulation 45, 52, 69, 71, 72, 88, 95, 97, [129] [130] [131] [132] . However, only some of the enriched elements correspond to sequences that have been shown to be bound by specific RNABPs and, in most cases, in vivo studies have not been performed yet to test the functional significance 
Small interfering RNA
RNA molecules that are 21-23 nucleotides long and that are processed from long double-stranded RNAs. They are functional components of the RNAi-induced silencing complex. They typically target and silence mRNAs by binding perfectly complementary sequences in the mRNA and causing their degradation and/ or translation inhibition.
Exon skipping
Exclusion of an exon from the resulting mature mRNA due to direct splicing of the upstream exon to the downstream exon.
Seed site
A short RNA sequence that is bound by and necessary for microRNA-mediated RNA regulation.
of suspected RNABP-RNA interactions. Interestingly, highly conserved intronic sequences that are associated with alternative splicing events are large enough to accommodate many RNABP-RNA interactions, which is consistent with the idea of combinatorial control that involves multiple RNABPs 52, 70, 71 . Recently, the complexity of RNABP action has begun to be addressed by combining genetic models with high-throughput biochemical, bioinformatic and RNA-profiling methods. Such studies have been facilitated by the development of animals with genetically modified RNABP expression -mouse knockouts 53, 88, [133] [134] [135] , transgenic mice 97 , morpholinotreated zebrafish embyros 136 or cultured cells in which the expression of specific RNABPs has been knocked down by small interfering RNAs (siRNAs) 69, 72, 90, [136] [137] [138] [139] . The use of high-throughput methods in conjunction with these models is now allowing the identification and functional validation of RNA-protein interactions on a transcriptome-wide scale.
The generation of transcriptome-wide maps of functional RNABP-RNA interactions is providing insights into the rules by which RNA complexity is regulated. For example, these studies have generated compelling evidence that the position of RNABP-RNA interactions in primary transcripts dictates the functional outcome of alternative pre-mRNA processing events (FIG. 4) . Initial ideas relating to Nova-mediated RNA regulation in mouse brain were provided by detailed studies of two transcripts studied in vitro and in tissue culture cells 134, 140, 141 . Subsequently, a combination of studies in Nova-knockout mice 142 , including exon-junction arrays 53 , bioinformatics 69, 134 and HITS-ClIP
88
, expanded these ideas into a general rule. In this work, and in subsequent studies of the FOX1/2 splicing factor that provided analogous findings 69, 72, 90 , it was shown that the binding of RNABPs in an alternative exon or the flanking upstream intronic sequence is generally associated with exon skipping, whereas the binding of RNABPs to the downstream intronic sequence is generally associated with exon inclusion (FIG. 4) .The extent to which such position-dependent regulation is a feature of other RNABPs is not currently known; however, there is reason to believe that such interactions with target pre-mRNAs may prove to be general features of RNABP regulation, based on bioinformatic and biochemical studies of other RNABPs, including MBNl, CelF, PTBP1 (REFS 69, 97) and several hnRNPs (A/B, l, ll, F and H) 41, 138 . The application of genetic systems and high-throughput approaches to identify transcriptome-wide interactions and assess their functional significance will provide a greater understanding of the mechanisms by which RNABPs act in isolation and combinatorially to regulate gene expression.
Mapping functional transcriptome-wide RNABP-RNA interactions in an unbiased manner can reveal unanticipated functions for RNABPs in generating RNA diversity and regulation. For example, HITS-ClIP combined with microarray analysis of wild-type and Nova2-knockout mouse brain led to the identification of an unexpected role for NOvA2 in regulating alternative polyadenylation in the brain 88 . Such studies illustrate a previously recognized point, albeit not made on a transcriptome-wide scale, for SR proteins and hnRNPs: RNABPs cannot be neatly allocated to a single functional category, rather they are multifunctional proteins that participate in many aspects of RNA biochemistry. HITS-ClIP analysis of the SR protein SRFS1 (previously known as ASF/SF2) in human embryonic kidney cells revealed an overrepresentation of SFRS1 binding to mRNAs encoding RNA regulatory proteins, which suggested the possibility that a regulatory loop exists 93 . Another new aspect of RNABP regulation emerged from ClIP analyses of HNRNPA1. These studies revealed that HNRNPA1 binds to the stem-loop sequences in the miRNA precursor pre-miR-18a 143 in Hela cells, and in so doing functions as an auxiliary factor to enhance Drosha-mediated processing to produce mature miR-18a 144 .
Recently, HITS-ClIP was extended to the study of ternary interactions between an RNABP (Ago), RNA and miRNAs 91 . These studies developed a genome-wide map of miRNA-binding sites in mouse brain transcripts. Such studies offer a means to resolve the difficulty bioinformatic approaches have had in identifying bona fide miRNA seed sites. In addition, they might also yield new rules of RNA regulation -27% of Ago-binding sites seemed to be 'orphans' in which no miRNA-binding site could be identified. Therefore, there might be new rules of miRNA-mRNA interactions that are yet to be elucidated by Ago HITS-ClIP maps.
RNA networks and biological coherence. Before the onset of high-throughput methods, several observations suggested that some level of biological coherence is established by RNA regulation -the idea that the coordinate regulation of RNAs that encode related proteins coordinates biological processes. Observations of biological coherence of RNA regulation during sex determination in D. melanogaster and iron response pathways in vertebrate cells in the 1990s were followed by more general hypotheses of functionally coherent networks in yeast, tissue culture cells and mouse brain, as recently discussed 95, 127, 145 . However, the inability to distinguish between direct and indirectly regulated RNAs has complicated the evaluation of such networks. Now the combination of genetic approaches, bioinformatics and biochemistry can be used to uncover functional roles and networks of RNABPs by rigorously identifying validated sets of transcripts and the biological functions of the encoded proteins (FIG. 4) . For example, analysis of RNA from wild-type and Novaknockout mouse brains using exon-junction microarrays 53 revealed that Nova regulates the alternative splicing of a biologically coherent set of transcripts that encode proteins with synaptic functions 53, 88, 95 . HITS-ClIP and bioinformatic studies 88 showed that a subset of these transcripts were directly regulated by Nova. This network could predict aspects of Nova physiology in the mouse brain, including roles in inhibitory potentiation in the hippocampus 146 and in motor neuron function 147 . Taken together, these studies provided the first demonstration in mammals of the coordinated activity of a RNABP in a biological network. Similarly, analysis of RNA regulatory defects in mouse knockouts of Sfrs1 (REFS 135,148), Nature Reviews | Genetics Biochemical methods as exemplified by HITS-CLIP can yield genome-wide footprints of direct RNA-protein interactions but lack functional information. By contrast, microarrays or RNA-seq can correlate differences in RNA profiles between tissues 45 or genetic systems, such as knockout (KO) and wild-type (WT) animals 53 , but cannot distinguish direct from indirect targets. Bioinformatic analysis can also be used to identify sequence features associated with specific RNA regulatory events 69 but still requires biochemical validation of putative regulatory interactions. Overlaying these approaches can yield powerful maps of functional RNA-protein interaction sites for neuro-oncological ventral antigen (Nova) 53, 88, 134 and FOX1/2 (REFS 72,90,139) proteins. Two important maps can be derived from combining these approaches; one biological (bottom right panel) and one mechanistic (bottom left panels). An assessment of the directly regulated mRNAs can address the extent to which there is a biological coherence to the set of target RNAs; for example, the first such assessment of a genome-wide, directly regulated validated set of targets revealed that Nova regulates RNAs that encode synaptic functions 53, 88, 95 . In addition, new rules of regulation can be derived from combining experiments to yield functional maps; for example, it became apparent that the position of protein binding in a transcript determines whether Nova 134 or FOX1/2 (REFS 69,72,90) binding enhances or inhibits the inclusion of alternative exons. m Srp38 (also known as Sfrs13a) 133 and Cebpd and Mbnl1 (REFS 97, 149) are poised to reveal the direct roles that different factors have in generating the specific alternative mRNA isoforms that are necessary for proper tissue development or function.
alternative mrnas and disease The importance of methods to probe mRNA complexity and understand mRNA regulation is underscored by the growing list of human diseases that are associated with defects in the expression of alternative mRNA isoforms 27, 94 . This list includes diseases that result from mutations that activate cryptic splice sites or disrupt sequences that are necessary for RNA processing, which lead to the alteration of specific protein isoforms or transcript destabilization. There is also a growing list of disorders that show changes in RNABP expression and/or activity owing to mutation, autoimmune targeting or sequestration of RNABPs. Such disorders seem to particularly affect complex tissues, and are exemplified by neurodegenerative disorders. RNABPs that have been linked to neurodegeneration include: FuS and TDP43, which are mutated in patients with familial amyotrophic lateral sclerosis (AlS) 150 ; Nova and the elav proteins, which are targeted by the immune system in paraneoplastic neurodegenerative disorders 78, 151 ; survival motor neuron protein 1 (SMN1), which is mutated in spinal muscular atrophy 27 ; immunoglobulin mu-binding protein 2 (IGHMBP2), which is mutated in spinal muscular atrophy and respiratory distress 152 ; senataxin, which is mutated in AlS4 (REF. 153); and glycyl tRNA synthetase, which is mutated in hereditary motor neuronopathy type v 154 . Moreover, a growing number of neurological disorders is believed to be linked to RNA expansions that sequester RNABPs, as exemplified by the sequestration of MBNl by CuG repeats in myotonic dystrophy 149 . Similarly, the deletion, mutation or inappropriate expression of miRNAs, which leads to mistargeting of the RNABP Ago and to aberrant RNA regulation 17 , is important in multiple disorders 27 , including neurological disease, cancer and autoimmunity. Although we are just beginning to appreciate the role of RNABPs in human disease, methods that allow researchers to overlay RNA sequence profiles and RNABP maps offer a new means of comparing protein-RNA interactions in normal and diseased tissues.
There are also many examples of defects in the expression of alternative mRNA isoforms and RNABPs in disease for which a defined causal relationship has not been shown. For example, microarray and high-throughput RT-PCR analyses have detected alternative splicing events associated with different types of cancer and have identified 'splicing signatures' associated with different histologically defined tumour subgroups 155 . It seems likely that the expression of aberrantly spliced transcripts will be found to contribute to tumour biology. efforts to identify alternative splicing markers associated with disease combined with bioinformatic analyses are providing insights into the mechanisms of RNA regulation that, when perturbed, might result in disease. For example, consensus binding sites for the FOX1/2 RNABPs were identified near many alternative exons that were mis-spliced in ovarian and breast cancer 156 . evidence suggesting that the Fox proteins directly regulate these alternative splicing events include decreased levels of FOX2 in ovarian cancer and the recapitulation of cancer-associated splicing defects by knockdown of FOX2 expression in cultured cells. Such efforts are providing new insights into the extent to which alternative mRNA isoforms correlate with and, in some cases, cause disease and how disruption of RNABPs that have tumour suppressor 156 or proto-oncogene 157 activities might lead to aberrant mRNA processing events that are associated with cancer. Considering the many ways in which alternative processing can affect gene expression, the ability to characterize RNA profiles and regulation in disease will be likely to play a major part in advancing our understanding of disease biology and assist in the development of strategies for therapeutic intervention.
concluding remarks and future directions Methodological advances in the twentieth century led to the realization that RNA complexity and RNA regulation lie at the core of biological complexity. In recent years, the advent of high-throughput strategies has allowed nucleotide-level analyses of RNA regulation and complexity on a genome-wide scale. These have revealed insights into the extent to which mRNA diversification contributes to cell-specific biology and the mechanisms by which this diversification is achieved. A challenge for the future will be to determine the extent to which different RNA isoforms contribute to biological complexity.
The complementary methods that are described in this Review each give powerful but incomplete data about RNA regulation: methods to enumerate RNA variants (microarrays and RNA-seq) and bioinformatic approaches are correlative, and biochemical crosslinking alone does not yield functional data. Importantly, combining these efforts (FIG. 4) offers the opportunity to identify and experimentally investigate different types of RNA regulatory mechanisms. Such studies have revealed that RNABPs regulate biologically coherent RNA networks, and the unanticipated mechanisms by which they do so are emerging. The variety of interactions that are evident from genome-wide studies of RNABPs emphasizes that they are multifunctional proteins, the activities of which are dependent on affinity constants and the local concentrations of proteins and their RNA substrates. Therefore, an important consideration for the future will be to consider how RNABPs act in the context of their local environment; for example, nuclear compartments, cytoplasmic P-bodies, stress granules and dendrites, as well as the effect that the accessibility of RNA targets has on RNABP activity.
Another challenge will be to take individual RNA maps -each based on genetics, bioinformatics and genome-wide biochemistry -and to superimpose them to give a more complete picture of how RNA regulation works inside a cell, in which hundreds of RNABPs simultaneously compete to regulate thousands of RNAs. Such pictures will be needed to interpret the dynamics of RNA-protein interactions during biological processes 158 .
The analysis of RNA-protein regulatory maps is also likely to yield insights into non-coding RNAs and their roles in coordinating gene regulation. Finally, the application of the methods and concepts reviewed here will advance our understanding of other RNA regulatory mechanisms. For example, translational control is beginning to be studied by using high-throughput methods: yeast translation was recently studied by using RNA-seq 159 to characterize polyribosomal RNA, and mouse genetics coupled to microarray profiles 160, 161 was used to profile transcribed mRNAs in individual neuronal subtypes. Combining the methods described in this Review with single-cell and, ultimately, subcellular analysis will offer the opportunity to understand RNA function in various cellular contexts. Such studies will enhance the discovery of how RNA regulation affects tissue complexity and disease by shaping the expression of genetic information.
